Dawn L. Hershman at Columbia University Irving Medical Center - Research Interests, Publications & Academic Profile

Dawn L. Hershman

Columbia University Irving Medical Center

United States

This profile is automatically generated from trusted academic sources.

Google Scholar

ORCID

How do Nigerian students reach out?

Meet Kite AI

Contact this professor

ORCID

Google Scholar

Research Interests

Pharmacotherapy

70%

Health Economics

40%

Oncology

40%

Pharmacoeconomics

30%

Cancer Therapy

30%

Healthcare Utilization

20%

Evidence-based Medicine

20%

Ask ApplyKite AI

Start chatting

How can you help me contact this professor?

What are this professor's research interests?

How should I write an email to this professor?

Articles11

Association Between Copayment Assistance, Insurance Type, Prior Authorization, and Time to Receipt of Oral Anticancer Drugs

Article Link

Year:

2024

Universal Viral Screening of Newly Diagnosed Cancer Patients in the United States: A Cost Efficiency Evaluation

Article Link

Year:

2023

Novel Approaches for Dynamic Visualization of Adverse Event Data in Oncology Clinical Trials: A Case Study Using Immunotherapy Trial S1400-I (SWOG)

Article Link

Year:

2023

Use of Opioids for Adults With Pain From Cancer or Cancer Treatment: ASCO Guideline

Article Link

Year:

2023

Effect of Metformin Versus Placebo on New Primary Cancers in Canadian Cancer Trials Group MA.32: A Secondary Analysis of a Phase III Randomized Double-Blind Trial in Early Breast Cancer

Article Link

Year:

2023

Impact of a Hospital-Based Specialty Pharmacy in Partnership With a Care Coordination Organization on Time to Delivery and Receipt of Oral Anticancer Drugs

Article Link

Year:

2023

Association Between Oncology Clinical Pathway Utilization and Toxicity and Cost Outcomes in Patients With Metastatic Solid Tumors

Article Link

Year:

2023

Metformin, placebo, and endocrine therapy discontinuation among participants in a randomized double-blind trial of metformin vs placebo in hormone receptor-positive early-stage breast cancer (CCTG MA32)

Article Link

Year:

2023

A Pragmatic Cluster-Randomized Trial of a Standing Order Entry Intervention for Colony-Stimulating Factor Use Among Patients at Intermediate Risk for Febrile Neutropenia

Article Link

Year:

2023

Efficacy of a password‐protected, pill‐dispensing device with mail return capacity to enhance disposal of unused opioids after cancer surgery

Article Link

Year:

2022

Association between immigrant status and advanced cancer patients' location and quality of death

Article Link

Year:

2022

Collaborators14

Judith Paice

Northwestern University Feinberg School of Medicine

UNITED STATES

Pamela Goodwin

Professor

University of Toronto

CANADA

Bingshu Chen

Professor

Queen's University

CANADA

Jason D. Wright

UNITED STATES

Joseph Michael Unger

Fred Hutchinson Cancer Research Center

UNITED STATES

Rashmi Chugh

UNITED STATES

Mary Redman

Fred Hutchinson Cancer Research Center

UNITED STATES

Scott Ramsey

Fred Hutchinson Cancer Research Center

UNITED STATES

Melissa P. Beauchemin

Columbia University Irving Medical Center

UNITED STATES

Lyudmila Bazhenova

University of California

UNITED STATES

Monica Tincopa

University of California, San Diego

UNITED STATES

Thomas LeBlanc

Associate Professor of Medicine

Duke University School of Medicine

UNITED STATES

Karen A. Gelmon

The University of British Columbia

CANADA

Jessica Hwang

The University of Texas MD Anderson Cancer Center

UNITED STATES

How do Nigerian students reach out?

Meet Kite AI